公司愿景——专注于原创药全球同步开发

为重大疾病治疗提供突破性创新产品
新药研发创业者的助推器
共同成长为全球具有影响力的制药企

 

地址:北京市经济开发区科创六街88号(生物医药园)F2楼

电话:010-56315466       传真:010-56315314

邮箱:hr@jacobiopharma.com

北京加科思科新药研发有限公司     京CIP07097878    中企动力提供技术支持

:

 

        At Jacobio, we are developing cancer treatments that have the potential to be first-in-class or best-in-class monotherapies, and core components of innovative combination treatments. We have successfully built up a talented and experienced research and development team, and are interested in collaborations with other complementary organizations. We believe the combination of cumulative capital, diverse product pipeline and local advantages in China, makes us a trusted partner of choice for global biopharmaceutical companies seeking to access the greater China market. We are committed to partnering with entrepreneurs, biotech and pharmaceutical companies around the world to jointly discover and develop innovative products that will bring meaningful cures with unmet medical need. At the moment, Jacobio is seeking for collaborations in the fields shown below:

License-in

  • Strategic partner for Greater China/Worldwide: highly innovative or globally differentiated projects in oncology or other disease area with unmet medical need.
  • Representative fields: targets with “first in class” potential in oncology or other disease with unmet medical need, pioneering technological platforms and projects (such as next generation cell therapy, gene editing, oncolytic virus, application of AI in drug development).

License-out

  • License-out/co-development of our products.
  • Strategic partner for combination therapy with our immunotherapy products.

If you would like additional information on partnering with Jacobio, please contact our business development team at:

bd@jacobiopharma.com, 86-10-56315466-8085